CPTX GMBH – Trademark Portfolio
Entity Type: 27
CPTX GMBH holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 5 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include CAPSITEC and GXSTRANDS. The owner is based in PLANEGG.
SEMMELWEISSTR. 1
PLANEGG D-82152 , DE
Showing of trademarks Trademarks
Trademark Classifications
CPTX GMBH's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does CPTX GMBH have?
CPTX GMBH has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.
What trademark classes does CPTX GMBH file in?
CPTX GMBH files trademarks across 5 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 44 (Medical Services), Class 40 (Treatment & Processing). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CPTX GMBH's most well-known trademarks?
CPTX GMBH's registered trademark portfolio includes well-known marks such as CAPSITEC and GXSTRANDS. These are among 3 currently registered trademarks in the portfolio.
What is CPTX GMBH's trademark registration success rate?
CPTX GMBH has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.